Ads
related to: jazz pharmaceuticals, fibromyalgia
Search results
Axsome (AXSM) up 118.4% in the Past Three Months: Here's Why
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics’ AXSM shares have surged 118.4% in the past three months against the industry’s...
Axsome (AXSM) Q3 Loss Narrower Than Expected, Revenues Miss
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics, Inc. AXSM incurred a loss of $1.03 per share (excluding intangible asset...
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
Motley Fool· 11 months agoMake money. That's every investor's goal. How each person chooses to achieve that goal makes the...
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Zacks via Yahoo Finance· 3 weeks agoAxsome Therapeutics, Inc. AXSM reported an adjusted loss of $1.00 per share for the first quarter of...
Axsome Triumphs Over Major Depressive Disorder With Auvelity
GuruFocus.com via Yahoo Finance· 2 months agoAxsome Therapeutics Inc. (NASDAQ:AXSM) is a fast-growing pharmaceutical company headquartered in New...
3 Biotech Stocks to Buy and Hold for the Next 10 Years
Motley Fool via Yahoo Finance· 3 months agoThe biotech industry can be risky and volatile, but there are advantages to investing in companies...
Axsome (AXSM) Q1 Earnings Beat Estimates, Auvelity Volume Rises
Zacks via Yahoo Finance· 1 year agoAxsome Therapeutics, Inc. AXSM incurred an adjusted loss 22 cents per share in the first quarter of...
3 Stocks Savvy Investors Are Buying Hand Over Fist
Motley Fool· 2 years agoWhile the SPDR S&P Healthcare ETF is down 10% year to date, the SPDR S&P Biotech ETF has plummeted 29%. Investors should always keep the long-term...
Axsome (AXSM) Q2 Earnings Beat, Stock Dips on Pipeline Updates
Zacks via Yahoo Finance· 10 months agoAxsome Therapeutics, Inc. AXSM incurred an adjusted loss $1.00 per share in the second quarter of...
This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.
Motley Fool· 11 months agoAxsome Therapeutics (NASDAQ: AXSM) started out last year as a small up-and-coming biotech company....
